🧠AI AnalysisFDA Approves First Factor XIa Inhibitor, Sunharbo, for Secondary Stroke Prevention
The U.S. Food and Drug Administration has approved Sunharbo as the first factor XIa inhibitor to help prevent secondary strokes when combined with antiplatelet therapy.

